Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Salesforce.com, Inc. (CRM) Stock Slugged by Weak Q3 Outlook

Salesforce.com reported a so-so quarter on Wednesday that sent CRM stock holders packing. The culprit: Weak Q3 guidance.

5 Stocks to Sell for September

These stocks to sell are suffering from deteriorating fundamentals and troubling charts. Worse: They're all regular losers in September.

Trouble Looms for Sirius XM Holdings Inc. (SIRI)

Sirius XM is overly dependent on the auto industry to thrive, and recent changes to the industry will create issues for SIRI stock

Biogen Inc (BIIB) Stock Is Too Much of a Coin Toss

Handicapping Biogen stock (BIIB) for the foreseeable future is too much guesswork, but if the wind blows the right way, look out above.

8 Machinery Stocks to Sell Now

This week, 8 Machinery stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Insurance Stocks to Sell Now

The overall ratings of 4 Insurance stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

6 Semiconductors & Semiconductor Equipment Stocks to Sell Now

This week, 6 Semiconductors & Semiconductor Equipment stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

9 Specialty Retail Stocks to Sell Now

This week, the overall grades of 9 Specialty Retail stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Capital Markets Stocks to Sell Now

The overall ratings of 7 Capital Markets stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Under Armour Inc (UA) Slips on Argus Downgrade to “Hold”

UA stock slipped on Wednesday after Argus analyst John Staszak expressed concern about Under Armour's future earnings growth.

5 Stocks With Awful Earnings Momentum — EMITF SAEX LVNTA GNK EGLE

This week, these five stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

Abercrombie & Fitch Co. (ANF) Reports More Trash Results

Another weak quarter shows how demography, technology and fashion trends have pushed Abercrombie & Fitch Co. (ANF) past its event horizon.

9 Health Care Providers & Services Stocks to Sell Now

This week, the ratings of 9 Health Care Providers & Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Multiline Retail Stocks to Sell Now

The ratings of 5 Multiline Retail stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Poor Free Cash Flow — I CCCL AAMC CZR ARL

This week, these five stocks have the worst ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Poor Earnings Growth — BBRY EMG ADSK STFC SPWR

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

Caesars Entertainment Corp (CZR): The Shell Game Is Over

A bankruptcy court judge just said Caesars Entertainment Corp (CZR) could be sued for deceiving, cheating Caesars Entertainment Operating Company lenders.

Square Inc (SQ) Downgrade Grinds This Run to a Halt

SQ stock has rebounded from its spring lows, but Square Inc is too volatile and unprofitable to trust.

Gilead Sciences, Inc. (GILD) Investors Are Drowning in Negativity

Gilead Sciences (GILD) stock takes yet another hit as a rival comes after Gilead Sciences' lucrative HIV treatment market.